Bay Area's second IPO ready to debut after raising $238M

Bay Area's second IPO ready to debut after raising $238M

bizjournals

Published

Revolution Medicines Inc. is set to start trading on the Nasdaq on Thursday after hitting the top of the IPO target range it boosted this week, raising $238 million. The Redwood City oncology biotech, led by CEO and President Mark Goldsmith, agreed to sell 14 million shares at $17 apiece, giving it an initial market cap of about $967 million going into its Wall Street debut. Insiders have options to buy about 2.1 million more shares at the offering price. The plan until this week was to sell 10…

Full Article